Metabolic Syndrome in Psychotic Disorder Patients Treated With Oral and Long-Acting Injected Antipsychotics

Metabolic Syndrome in Psychotic Disorder Patients Treated With Oral and Long-Acting Injected Antipsychotics

Background: Severe mental illnesses are associated with increased risks for metabolic syndrome (MetS) and other medical disorders, often with unfavorable outcomes. MetS may be more likely with schizoaffective disorder (SzAff) than schizophrenia (Sz). MetS is associated with long-term antipsychotic d...

Full description

Bibliographic Details
Main Authors: Antonio Ventriglio, Ross J. Baldessarini, Giovanna Vitrani, Iris Bonfitto, Angela Chiara Cecere, Angelo Rinaldi, Annamaria Petito, Antonello Bellomo
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-01-01
Series:Frontiers in Psychiatry
Subjects:
metabolic syndrome
antipsychotics
long-acting injected
schizoaffective
schizophrenia
Online Access:https://www.frontiersin.org/article/10.3389/fpsyt.2018.00744/full

Internet

https://www.frontiersin.org/article/10.3389/fpsyt.2018.00744/full

Similar Items